We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Community Health Systems
CYH
$437M
| $34K | ﹤0.01% |
11,559
+1,536
| +15% | +$4.97K |
|
1652
Allogene Therapeutics
ALLO
$614M
| $33.4K | ﹤0.01% |
13,672
+1,867
| +16% | +$3.74K |
|
1653
Altimmune
ALT
$546M
| $33.2K | ﹤0.01% |
+10,783
| New | +$45.8K |
|
1654
Pacific Biosciences
PACB
$419M
| $32.7K | ﹤0.01% |
24,777
+3,310
| +15% | +$5.92K |
|
1655
Akebia Therapeutics
AKBA
$343M
| $31.7K | ﹤0.01% |
22,782
+2,837
| +14% | +$3.9K |
|
1656
Richtech Robotics
RR
$356M
| $31.1K | ﹤0.01% |
14,867
+3,003
| +25% | +$9.23K |
|
1657
Blend Labs
BLND
$433M
| $30.8K | ﹤0.01% |
18,120
+2,366
| +15% | +$5.06K |
|
|
OPTU
1658
Optimum Communications Inc
OPTU
$327M
| $30.6K | ﹤0.01% |
23,569
+3,133
| +15% | +$4.92K |
|
1659
American Battery Technology Co
ABAT
$312M
| $30.3K | ﹤0.01% |
+10,875
| New | +$42K |
|
1660
Cerus
CERS
$645M
| $30.1K | ﹤0.01% |
16,536
+2,214
| +15% | +$4.82K |
|
1661
Real Brokerage
REAX
$440M
| $30K | ﹤0.01% |
12,013
+1,694
| +16% | +$5.12K |
|
|
EU
1662
enCore Energy
EU
$229M
| $29.8K | ﹤0.01% |
16,567
+2,208
| +15% | +$5.64K |
|
|
NXDR
1663
Nextdoor Holdings
NXDR
$919M
| $27.5K | ﹤0.01% |
19,671
+2,666
| +16% | +$4.63K |
|
1664
Microvast
MVST
$301M
| $27.2K | ﹤0.01% |
18,120
+2,386
| +15% | +$5.75K |
|
|
OLPX
1665
DELISTED
Olaplex Holdings
OLPX
| $26K | ﹤0.01% |
12,804
+1,684
| +15% | +$2.58K |
|
1666
Standard BioTools
LAB
$333M
| $24.9K | ﹤0.01% |
27,043
+3,446
| +15% | +$4.17K |
|
1667
Beyond Meat
BYND
$298M
| $24.5K | ﹤0.01% |
34,925
+5,032
| +17% | +$4.02K |
|
1668
Evolent Health
EVH
$650M
| $24K | ﹤0.01% |
+10,524
| New | +$33.4K |
|
1669
3D Systems Corp
DDD
$423M
| $23.6K | ﹤0.01% |
+12,545
| New | +$27.9K |
|
1670
Alight
ALIT
$541M
| $23K | ﹤0.01% |
1,975
+261
| +15% | +$6.22K |
|
|
RC
1671
Ready Capital
RC
$253M
| $22.2K | ﹤0.01% |
13,674
+1,569
| +13% | +$3K |
|
1672
8x8 Inc
EGHT
$271M
| $20K | ﹤0.01% |
12,038
+1,646
| +16% | +$3.37K |
|
1673
Hyliion Holdings
HYLN
$647M
| $19.9K | ﹤0.01% |
+11,303
| New | +$22.7K |
|
1674
EVgo
EVGO
$236M
| $19.8K | ﹤0.01% |
+11,503
| New | +$30.8K |
|
|
SVC
1675
Service Properties Trust
SVC
$1.14B
| $18.9K | ﹤0.01% |
2,787
+376
| +16% | +$3.91K |
|
Similar funds
CM
ETC
BIP
FGP
BPC
SSA
TI
BBVA
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.